APO Research

APO RESEARCH · REPORT

Yellow Nail Syndrome Treatment

Selected research

Market Structure

Global Yellow Nail Syndrome Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Yellow Nail Syndrome Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Yellow Nail Syndrome Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Yellow Nail Syndrome Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Yellow Nail Syndrome Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Yellow Nail Syndrome Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Yellow Nail Syndrome Treatment include Abbott, Sanofi, Johnson & Johnson, Novartis, Merck, Merck, Mylan, Roche and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Yellow Nail Syndrome Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Yellow Nail Syndrome Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Yellow Nail Syndrome Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Yellow Nail Syndrome Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Yellow Nail Syndrome Treatment Segment by Company

Abbott

Sanofi

Johnson & Johnson

Novartis

Merck

Merck

Mylan

Roche

Pfizer

GlaxoSmithKline

Bayer

AstraZeneca

Teva Pharmaceutical

Sun Pharmaceutical

Sumitomo Corporation

Enzon Pharmaceuticals

Cipla

Allergan

Yellow Nail Syndrome Treatment Segment by Type

Capsule

Cream

Tablet

Injection

Others

Yellow Nail Syndrome Treatment Segment by Application

Hospital

Clinic

Others

Yellow Nail Syndrome Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Yellow Nail Syndrome Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Yellow Nail Syndrome Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Yellow Nail Syndrome Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Yellow Nail Syndrome Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Yellow Nail Syndrome Treatment industry.

Chapter 3: Detailed analysis of Yellow Nail Syndrome Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Yellow Nail Syndrome Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Yellow Nail Syndrome Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Capsule Table 3. Key Players of Cream Table 4. Key Players of Tablet Table 3. Key Players of Injection Table 4. Key Players of Others Table 5. Global Yellow Nail Syndrome Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Hospital Table 7. Key Players of Clinic Table 8. Key Players of Others Table 9. Global Yellow Nail Syndrome Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Yellow Nail Syndrome Treatment Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Yellow Nail Syndrome Treatment Market Share by Region (2021-2026) Table 12. Global Yellow Nail Syndrome Treatment Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Yellow Nail Syndrome Treatment Market Share by Region (2027-2032) Table 14. Yellow Nail Syndrome Treatment Industry Trends Table 15. Yellow Nail Syndrome Treatment Industry Drivers Table 16. Yellow Nail Syndrome Treatment Industry Opportunities and Challenges Table 17. Yellow Nail Syndrome Treatment Industry Restraints Table 18. Global Yellow Nail Syndrome Treatment Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Yellow Nail Syndrome Treatment Revenue Market Share by Company (2021-2026) Table 20. Global Yellow Nail Syndrome Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Yellow Nail Syndrome Treatment Key Company Head Office and Area Served Table 22. Global Yellow Nail Syndrome Treatment Company, Product Type & Application Table 23. Global Yellow Nail Syndrome Treatment Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Yellow Nail Syndrome Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Yellow Nail Syndrome Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Yellow Nail Syndrome Treatment Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Yellow Nail Syndrome Treatment Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Yellow Nail Syndrome Treatment Revenue Market Share by Type (2021-2026) Table 30. Global Yellow Nail Syndrome Treatment Revenue Market Share by Type (2027-2032) Table 31. Global Yellow Nail Syndrome Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Yellow Nail Syndrome Treatment Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Yellow Nail Syndrome Treatment Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Yellow Nail Syndrome Treatment Revenue Market Share by Application (2021-2026) Table 35. Global Yellow Nail Syndrome Treatment Revenue Market Share by Application (2027-2032) Table 36. Abbott Company Information Table 37. Abbott Business Overview Table 38. Abbott Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Abbott Yellow Nail Syndrome Treatment Product Portfolio Table 40. Abbott Recent Development Table 41. Sanofi Company Information Table 42. Sanofi Business Overview Table 43. Sanofi Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Sanofi Yellow Nail Syndrome Treatment Product Portfolio Table 45. Sanofi Recent Development Table 46. Johnson & Johnson Company Information Table 47. Johnson & Johnson Business Overview Table 48. Johnson & Johnson Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Johnson & Johnson Yellow Nail Syndrome Treatment Product Portfolio Table 50. Johnson & Johnson Recent Development Table 51. Novartis Company Information Table 52. Novartis Business Overview Table 53. Novartis Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Novartis Yellow Nail Syndrome Treatment Product Portfolio Table 55. Novartis Recent Development Table 56. Merck Company Information Table 57. Merck Business Overview Table 58. Merck Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Merck Yellow Nail Syndrome Treatment Product Portfolio Table 60. Merck Recent Development Table 61. Merck Company Information Table 62. Merck Business Overview Table 63. Merck Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Merck Yellow Nail Syndrome Treatment Product Portfolio Table 65. Merck Recent Development Table 66. Mylan Company Information Table 67. Mylan Business Overview Table 68. Mylan Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Mylan Yellow Nail Syndrome Treatment Product Portfolio Table 70. Mylan Recent Development Table 71. Roche Company Information Table 72. Roche Business Overview Table 73. Roche Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Roche Yellow Nail Syndrome Treatment Product Portfolio Table 75. Roche Recent Development Table 76. Pfizer Company Information Table 77. Pfizer Business Overview Table 78. Pfizer Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Pfizer Yellow Nail Syndrome Treatment Product Portfolio Table 80. Pfizer Recent Development Table 81. GlaxoSmithKline Company Information Table 82. GlaxoSmithKline Business Overview Table 83. GlaxoSmithKline Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. GlaxoSmithKline Yellow Nail Syndrome Treatment Product Portfolio Table 85. GlaxoSmithKline Recent Development Table 86. Bayer Company Information Table 87. Bayer Business Overview Table 88. Bayer Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Bayer Yellow Nail Syndrome Treatment Product Portfolio Table 90. Bayer Recent Development Table 91. AstraZeneca Company Information Table 92. AstraZeneca Business Overview Table 93. AstraZeneca Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. AstraZeneca Yellow Nail Syndrome Treatment Product Portfolio Table 95. AstraZeneca Recent Development Table 96. Teva Pharmaceutical Company Information Table 97. Teva Pharmaceutical Business Overview Table 98. Teva Pharmaceutical Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Teva Pharmaceutical Yellow Nail Syndrome Treatment Product Portfolio Table 100. Teva Pharmaceutical Recent Development Table 101. Sun Pharmaceutical Company Information Table 102. Sun Pharmaceutical Business Overview Table 103. Sun Pharmaceutical Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Sun Pharmaceutical Yellow Nail Syndrome Treatment Product Portfolio Table 105. Sun Pharmaceutical Recent Development Table 106. Sumitomo Corporation Company Information Table 107. Sumitomo Corporation Business Overview Table 108. Sumitomo Corporation Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. Sumitomo Corporation Yellow Nail Syndrome Treatment Product Portfolio Table 110. Sumitomo Corporation Recent Development Table 111. Enzon Pharmaceuticals Company Information Table 112. Enzon Pharmaceuticals Business Overview Table 113. Enzon Pharmaceuticals Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. Enzon Pharmaceuticals Yellow Nail Syndrome Treatment Product Portfolio Table 115. Enzon Pharmaceuticals Recent Development Table 116. Cipla Company Information Table 117. Cipla Business Overview Table 118. Cipla Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. Cipla Yellow Nail Syndrome Treatment Product Portfolio Table 120. Cipla Recent Development Table 121. Allergan Company Information Table 122. Allergan Business Overview Table 123. Allergan Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 124. Allergan Yellow Nail Syndrome Treatment Product Portfolio Table 125. Allergan Recent Development Table 126. North America Yellow Nail Syndrome Treatment Market Size by Type (2021-2026) & (US$ Million) Table 127. North America Yellow Nail Syndrome Treatment Market Size by Type (2027-2032) & (US$ Million) Table 128. North America Yellow Nail Syndrome Treatment Market Size by Application (2021-2026) & (US$ Million) Table 129. North America Yellow Nail Syndrome Treatment Market Size by Application (2027-2032) & (US$ Million) Table 130. North America Yellow Nail Syndrome Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. North America Yellow Nail Syndrome Treatment Market Size by Country (2021-2026) Table 132. North America Yellow Nail Syndrome Treatment Market Size by Country (2027-2032) Table 133. Europe Yellow Nail Syndrome Treatment Market Size by Type (2021-2026) & (US$ Million) Table 134. Europe Yellow Nail Syndrome Treatment Market Size by Type (2027-2032) & (US$ Million) Table 135. Europe Yellow Nail Syndrome Treatment Market Size by Application (2021-2026) & (US$ Million) Table 136. Europe Yellow Nail Syndrome Treatment Market Size by Application (2027-2032) & (US$ Million) Table 137. Europe Yellow Nail Syndrome Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Europe Yellow Nail Syndrome Treatment Market Size by Country (2021-2026) Table 139. Europe Yellow Nail Syndrome Treatment Market Size by Country (2027-2032) Table 140. China Yellow Nail Syndrome Treatment Market Size by Type (2021-2026) & (US$ Million) Table 141. China Yellow Nail Syndrome Treatment Market Size by Type (2027-2032) & (US$ Million) Table 142. China Yellow Nail Syndrome Treatment Market Size by Application (2021-2026) & (US$ Million) Table 143. China Yellow Nail Syndrome Treatment Market Size by Application (2027-2032) & (US$ Million) Table 144. Asia Yellow Nail Syndrome Treatment Market Size by Type (2021-2026) & (US$ Million) Table 145. Asia Yellow Nail Syndrome Treatment Market Size by Type (2027-2032) & (US$ Million) Table 146. Asia Yellow Nail Syndrome Treatment Market Size by Application (2021-2026) & (US$ Million) Table 147. Asia Yellow Nail Syndrome Treatment Market Size by Application (2027-2032) & (US$ Million) Table 148. Asia Yellow Nail Syndrome Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Asia Yellow Nail Syndrome Treatment Market Size by Country (2021-2026) Table 150. Asia Yellow Nail Syndrome Treatment Market Size by Country (2027-2032) Table 151. South America, Middle East & Africa Yellow Nail Syndrome Treatment Market Size by Type (2021-2026) & (US$ Million) Table 152. South America, Middle East & Africa Yellow Nail Syndrome Treatment Market Size by Type (2027-2032) & (US$ Million) Table 153. South America, Middle East & Africa Yellow Nail Syndrome Treatment Market Size by Application (2021-2026) & (US$ Million) Table 154. South America, Middle East & Africa Yellow Nail Syndrome Treatment Market Size by Application (2027-2032) & (US$ Million) Table 155. South America, Middle East & Africa Yellow Nail Syndrome Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. South America, Middle East & Africa Yellow Nail Syndrome Treatment Market Size by Country (2021-2026) Table 157. South America, Middle East & Africa Yellow Nail Syndrome Treatment Market Size by Country (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. Yellow Nail Syndrome Treatment Product Image Figure 2. Global Yellow Nail Syndrome Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Yellow Nail Syndrome Treatment Market Share by Type: 2025 VS 2032 Figure 4. Capsule Image Figure 5. Cream Image Figure 6. Tablet Image Figure 7. Injection Image Figure 8. Others Image Figure 9. Global Yellow Nail Syndrome Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Yellow Nail Syndrome Treatment Market Share by Application: 2025 VS 2032 Figure 11. Hospital Image Figure 12. Clinic Image Figure 13. Others Image Figure 14. Global Yellow Nail Syndrome Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 16. Global Yellow Nail Syndrome Treatment Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Yellow Nail Syndrome Treatment Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Yellow Nail Syndrome Treatment Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Yellow Nail Syndrome Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Yellow Nail Syndrome Treatment Revenue Market Share by Type (2021-2032) Figure 23. Global Yellow Nail Syndrome Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Yellow Nail Syndrome Treatment Revenue Market Share by Application (2021-2032) Figure 25. North America Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 26. North America Yellow Nail Syndrome Treatment Market Share by Type (2021-2032) Figure 27. North America Yellow Nail Syndrome Treatment Market Share by Application (2021-2032) Figure 28. North America Yellow Nail Syndrome Treatment Market Share by Country (2021-2032) Figure 29. United States Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Canada Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 32. Europe Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 33. Europe Yellow Nail Syndrome Treatment Market Share by Type (2021-2032) Figure 34. Europe Yellow Nail Syndrome Treatment Market Share by Application (2021-2032) Figure 35. Europe Yellow Nail Syndrome Treatment Market Share by Country (2021-2032) Figure 36. Germany Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 37. France Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 39. Italy Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 40. Russia Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 42. China Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 43. China Yellow Nail Syndrome Treatment Market Share by Type (2021-2032) Figure 44. China Yellow Nail Syndrome Treatment Market Share by Application (2021-2032) Figure 45. Asia Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 46. Asia Yellow Nail Syndrome Treatment Market Share by Type (2021-2032) Figure 47. Asia Yellow Nail Syndrome Treatment Market Share by Application (2021-2032) Figure 48. Asia Yellow Nail Syndrome Treatment Market Share by Country (2021-2032) Figure 49. Japan Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 53. India Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 54. Australia Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Yellow Nail Syndrome Treatment Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Yellow Nail Syndrome Treatment Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Yellow Nail Syndrome Treatment Market Share by Country (2021-2032) Figure 59. Brazil Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 64. UAE Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 66. Chile Yellow Nail Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Capsule
  • Cream
  • Tablet
  • Injection
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Abbott
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck
  • Merck
  • Mylan
  • Roche
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • AstraZeneca
  • Teva Pharmaceutical
  • Sun Pharmaceutical
  • Sumitomo Corporation
  • Enzon Pharmaceuticals
  • Cipla
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Yellow Nail Syndrome Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Capsule
  5. 1.2.3 Cream
  6. 1.2.4 Tablet
  7. 1.2.5 Injection
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Yellow Nail Syndrome Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital
  12. 1.3.3 Clinic
  13. 1.3.4 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Yellow Nail Syndrome Treatment Growth Trends by Region
  16. 1.5.1 Global Yellow Nail Syndrome Treatment Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Yellow Nail Syndrome Treatment Market Size by Region (2021-2026)
  18. 1.5.3 Yellow Nail Syndrome Treatment Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Yellow Nail Syndrome Treatment Market Dynamics
  1. 2.1 Yellow Nail Syndrome Treatment Industry Trends
  2. 2.2 Yellow Nail Syndrome Treatment Industry Drivers
  3. 2.3 Yellow Nail Syndrome Treatment Industry Opportunities and Challenges
  4. 2.4 Yellow Nail Syndrome Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Yellow Nail Syndrome Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Yellow Nail Syndrome Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Yellow Nail Syndrome Treatment Key Company Head office and Area Served
  4. 3.4 Global Yellow Nail Syndrome Treatment Company, Product Type & Application
  5. 3.5 Global Yellow Nail Syndrome Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Yellow Nail Syndrome Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Yellow Nail Syndrome Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Yellow Nail Syndrome Treatment Tier 1, Tier 2, and Tier 3
4 Yellow Nail Syndrome Treatment Market by Type
  1. 4.1 Global Yellow Nail Syndrome Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Yellow Nail Syndrome Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Yellow Nail Syndrome Treatment Market Size Share by Type (2021-2032)
5 Yellow Nail Syndrome Treatment Market by Application
  1. 5.1 Global Yellow Nail Syndrome Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Yellow Nail Syndrome Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Yellow Nail Syndrome Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Abbott Yellow Nail Syndrome Treatment Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Sanofi Yellow Nail Syndrome Treatment Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Johnson & Johnson
  14. 6.3.1 Johnson & Johnson Company Information
  15. 6.3.2 Johnson & Johnson Business Overview
  16. 6.3.3 Johnson & Johnson Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Johnson & Johnson Yellow Nail Syndrome Treatment Product Portfolio
  18. 6.3.5 Johnson & Johnson Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Novartis Yellow Nail Syndrome Treatment Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Merck
  26. 6.5.1 Merck Company Information
  27. 6.5.2 Merck Business Overview
  28. 6.5.3 Merck Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Merck Yellow Nail Syndrome Treatment Product Portfolio
  30. 6.5.5 Merck Recent Developments
  31. 6.6 Merck
  32. 6.6.1 Merck Company Information
  33. 6.6.2 Merck Business Overview
  34. 6.6.3 Merck Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Merck Yellow Nail Syndrome Treatment Product Portfolio
  36. 6.6.5 Merck Recent Developments
  37. 6.7 Mylan
  38. 6.7.1 Mylan Company Information
  39. 6.7.2 Mylan Business Overview
  40. 6.7.3 Mylan Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Mylan Yellow Nail Syndrome Treatment Product Portfolio
  42. 6.7.5 Mylan Recent Developments
  43. 6.8 Roche
  44. 6.8.1 Roche Company Information
  45. 6.8.2 Roche Business Overview
  46. 6.8.3 Roche Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Roche Yellow Nail Syndrome Treatment Product Portfolio
  48. 6.8.5 Roche Recent Developments
  49. 6.9 Pfizer
  50. 6.9.1 Pfizer Company Information
  51. 6.9.2 Pfizer Business Overview
  52. 6.9.3 Pfizer Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Pfizer Yellow Nail Syndrome Treatment Product Portfolio
  54. 6.9.5 Pfizer Recent Developments
  55. 6.10 GlaxoSmithKline
  56. 6.10.1 GlaxoSmithKline Company Information
  57. 6.10.2 GlaxoSmithKline Business Overview
  58. 6.10.3 GlaxoSmithKline Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 GlaxoSmithKline Yellow Nail Syndrome Treatment Product Portfolio
  60. 6.10.5 GlaxoSmithKline Recent Developments
  61. 6.11 Bayer
  62. 6.11.1 Bayer Company Information
  63. 6.11.2 Bayer Business Overview
  64. 6.11.3 Bayer Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Bayer Yellow Nail Syndrome Treatment Product Portfolio
  66. 6.11.5 Bayer Recent Developments
  67. 6.12 AstraZeneca
  68. 6.12.1 AstraZeneca Company Information
  69. 6.12.2 AstraZeneca Business Overview
  70. 6.12.3 AstraZeneca Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 AstraZeneca Yellow Nail Syndrome Treatment Product Portfolio
  72. 6.12.5 AstraZeneca Recent Developments
  73. 6.13 Teva Pharmaceutical
  74. 6.13.1 Teva Pharmaceutical Company Information
  75. 6.13.2 Teva Pharmaceutical Business Overview
  76. 6.13.3 Teva Pharmaceutical Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Teva Pharmaceutical Yellow Nail Syndrome Treatment Product Portfolio
  78. 6.13.5 Teva Pharmaceutical Recent Developments
  79. 6.14 Sun Pharmaceutical
  80. 6.14.1 Sun Pharmaceutical Company Information
  81. 6.14.2 Sun Pharmaceutical Business Overview
  82. 6.14.3 Sun Pharmaceutical Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Sun Pharmaceutical Yellow Nail Syndrome Treatment Product Portfolio
  84. 6.14.5 Sun Pharmaceutical Recent Developments
  85. 6.15 Sumitomo Corporation
  86. 6.15.1 Sumitomo Corporation Company Information
  87. 6.15.2 Sumitomo Corporation Business Overview
  88. 6.15.3 Sumitomo Corporation Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Sumitomo Corporation Yellow Nail Syndrome Treatment Product Portfolio
  90. 6.15.5 Sumitomo Corporation Recent Developments
  91. 6.16 Enzon Pharmaceuticals
  92. 6.16.1 Enzon Pharmaceuticals Company Information
  93. 6.16.2 Enzon Pharmaceuticals Business Overview
  94. 6.16.3 Enzon Pharmaceuticals Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Enzon Pharmaceuticals Yellow Nail Syndrome Treatment Product Portfolio
  96. 6.16.5 Enzon Pharmaceuticals Recent Developments
  97. 6.17 Cipla
  98. 6.17.1 Cipla Company Information
  99. 6.17.2 Cipla Business Overview
  100. 6.17.3 Cipla Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Cipla Yellow Nail Syndrome Treatment Product Portfolio
  102. 6.17.5 Cipla Recent Developments
  103. 6.18 Allergan
  104. 6.18.1 Allergan Company Information
  105. 6.18.2 Allergan Business Overview
  106. 6.18.3 Allergan Yellow Nail Syndrome Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Allergan Yellow Nail Syndrome Treatment Product Portfolio
  108. 6.18.5 Allergan Recent Developments
7 North America
  1. 7.1 North America Yellow Nail Syndrome Treatment Market Size (2021-2032)
  2. 7.2 North America Yellow Nail Syndrome Treatment Market Size by Type
  3. 7.2.1 North America Yellow Nail Syndrome Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Yellow Nail Syndrome Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Yellow Nail Syndrome Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Yellow Nail Syndrome Treatment Market Size by Application
  7. 7.3.1 North America Yellow Nail Syndrome Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Yellow Nail Syndrome Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Yellow Nail Syndrome Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Yellow Nail Syndrome Treatment Market Size by Country
  11. 7.4.1 North America Yellow Nail Syndrome Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Yellow Nail Syndrome Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Yellow Nail Syndrome Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Yellow Nail Syndrome Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Yellow Nail Syndrome Treatment Market Size (2021-2032)
  2. 8.2 Europe Yellow Nail Syndrome Treatment Market Size by Type
  3. 8.2.1 Europe Yellow Nail Syndrome Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Yellow Nail Syndrome Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Yellow Nail Syndrome Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Yellow Nail Syndrome Treatment Market Size by Application
  7. 8.3.1 Europe Yellow Nail Syndrome Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Yellow Nail Syndrome Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Yellow Nail Syndrome Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Yellow Nail Syndrome Treatment Market Size by Country
  11. 8.4.1 Europe Yellow Nail Syndrome Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Yellow Nail Syndrome Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Yellow Nail Syndrome Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Yellow Nail Syndrome Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Yellow Nail Syndrome Treatment Market Size (2021-2032)
  2. 9.2 China Yellow Nail Syndrome Treatment Market Size by Type
  3. 9.2.1 China Yellow Nail Syndrome Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Yellow Nail Syndrome Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Yellow Nail Syndrome Treatment Market Share by Type (2021-2032)
  6. 9.3 China Yellow Nail Syndrome Treatment Market Size by Application
  7. 9.3.1 China Yellow Nail Syndrome Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Yellow Nail Syndrome Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Yellow Nail Syndrome Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Yellow Nail Syndrome Treatment Market Size (2021-2032)
  2. 10.2 Asia Yellow Nail Syndrome Treatment Market Size by Type
  3. 10.2.1 Asia Yellow Nail Syndrome Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Yellow Nail Syndrome Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Yellow Nail Syndrome Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Yellow Nail Syndrome Treatment Market Size by Application
  7. 10.3.1 Asia Yellow Nail Syndrome Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Yellow Nail Syndrome Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Yellow Nail Syndrome Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Yellow Nail Syndrome Treatment Market Size by Country
  11. 10.4.1 Asia Yellow Nail Syndrome Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Yellow Nail Syndrome Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Yellow Nail Syndrome Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Yellow Nail Syndrome Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Yellow Nail Syndrome Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Yellow Nail Syndrome Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Yellow Nail Syndrome Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Yellow Nail Syndrome Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Yellow Nail Syndrome Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Yellow Nail Syndrome Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Yellow Nail Syndrome Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Yellow Nail Syndrome Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Yellow Nail Syndrome Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Yellow Nail Syndrome Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Yellow Nail Syndrome Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Yellow Nail Syndrome Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Yellow Nail Syndrome Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Yellow Nail Syndrome Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research